Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Dobutamine Hcl Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Dobutamine Hcl Manufacturers in India Suppliers Dobutamine Hcl Exporters Distributors Dobutamine Hcl api active pharmaceuticals ingredients Dobutamine Hcl manufacturers Side Effects bulk drugs raw material Dobutamine Hcl companies Side Effects Importers Dobutamine Hcl Dobutamine Hcl Exporters Dobutamine Hcl exporters FDA Dobutamine Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Dobutamine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Dobutamine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Dobutamine Hydrochloride active pharmaceutical ingredients Dobutamine Hydrochloride committee active pharmaceutical ingredients manufacturer Dobutamine Hydrochloride Active Pharmaceutical Ingredients manufacturer Dobutamine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Dobutamine Hcl, Dobutamine Hcl manufacturer India, Dobutamine Hcl product, Dobutamine Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Dobutamine Hcl anti ulcer product, Certificate of Origin COA Dobutamine Hcl COS Dobutamine Hcl, pharmaceutical generic, pharmaceutical drug, medical, Dobutamine Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Dobutamine Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Dobutamine Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Dobutamine Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Dobutamine Hcl ingredients, api, HIV Dobutamine Hcl, tablets, capsules, syrup & protein Dobutamine Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Dobutamine Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Dobutamine Hcl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

CAS Number 52663-81-7



 



















 

HOME >> API >> API List1 >> Dobutamine Hcl >> Side Effects

Dobutamine Hcl CAS Number 52663-81-7

SIDE EFFECTS
Dobutamine CAS Number 49745-95-1

Increased Heart Rate, Blood Pressure, and Ventricular Ectopic Activity− A 10 to 20 mm increase in systolic blood pressure and an increase in heart rate of 5 to 15 beats/minute have been noted in most patients (see WARNINGS regarding exaggerated chronotropic and pressor effects). Approximately 5% of patients have had increased premature ventricular beats during infusions. These effects are dose related.

Hypotension− Precipitous decreases in blood pressure have occasionally been described in association with Dobutamine therapy. Decreasing the dose or discontinuing the infusion typically results in rapid return of blood pressure to baseline values. In rare cases, however, intervention may be required and reversibility may not be immediate.

Reactions at Sites of Intravenous Infusion− Phlebitis has occasionally been reported. Local inflammatory changes have been described following inadvertent infiltration. Isolated cases of cutaneous necrosis (destruction of skin tissue) have been reported.

Miscellaneous Uncommon Effects− The following adverse effects have been reported in 1% to 3% of patients: nausea, headache, anginal pain, nonspecific chest pain, palpitations, and shortness of breath. Isolated cases of thrombocytopenia have been reported.

Administration of Dobutamine hydrochloride, like other catecholamines, can produce a mild reduction in serum potassium concentration, rarely to hypokalemic levels (see PRECAUTIONS).

Longer-Term Safety− Infusions of up to 72 hours have revealed no adverse effects other than those seen with shorter infusions.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS >>
PRECAUTIONS
INTERACTION
PHARMALOGY
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Dobutamine Hcl

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.